The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.
Chemical Modification of siRNAs for In Vivo Use
Abstract
Well over a hundred reports have been published describing use of synthetic small-interfering RNAs (siRNAs) in animals. The majority of these reports employed unmodified RNA duplexes. While unmodified RNA is the natural effector molecule of RNA interference, certain problems arise with experimental or therapeutic use of RNA duplexes in vivo, some of which can be improved or solved through use of chemical modifications. Judicious use of chemical modifications can improve the nuclease stability of an RNA duplex, decrease the likelihood of triggering an innate immune response, lower the incidence of off-target effects (OTEs), and improve pharmacodynamics. This review will examine studies that document the utility of various chemical modifications for use in siRNAs, both in vitro and in vivo, with close attention given to reports demonstrating actual performance in animal model systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
(2008) · doi:10.1038/nrg2290 · Cited by 5,199
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S., & Johnson, J. M. (2005) · Nature · doi:10.1038/nature03315 · Cited by 4,755
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H., & Bauer, S. (2004) · Science · doi:10.1126/science.1093620 · Cited by 3,947
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., Imaizumi, T., Miyagishi, M., Taira, K., Akira, S., & Fujita, T. (2004) · Nature Immunology · doi:10.1038/ni1087 · Cited by 3,929
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K., Uematsu, S., Jung, A., Kawai, T., Ishii, K. J., et al. (2006) · Nature · doi:10.1038/nature04734 · Cited by 3,888
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444
Karikó, K., Buckstein, M., Ni, H., & Weissman, D. (2005) · Immunity · doi:10.1016/j.immuni.2005.06.008 · Cited by 2,728
MicroRNA biogenesis: coordinated cropping and dicing
Kim, V. N. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1644 · Cited by 2,546
Mechanisms of gene silencing by double-stranded RNA
Meister, G., & Tuschl, T. (2004) · Nature · doi:10.1038/nature02873 · Cited by 2,539
5'-Triphosphate RNA Is the Ligand for RIG-I
Hornung, V., Ellegast, J., Kim, S., Brzózka, K., Jung, A., Kato, H., Poeck, H., Akira, S., Conzelmann, K.-K., Schlee, M., et al. (2006) · Science · doi:10.1126/science.1132505 · Cited by 2,474
Expression profiling reveals off-target gene regulation by RNAi
Jackson, A. L., Bartz, S. R., Schelter, J., Kobayashi, S. V., Burchard, J., Mao, M., Li, B., Cavet, G., & Linsley, P. S. (2003) · Nature Biotechnology · doi:10.1038/nbt831 · Cited by 2,370
Pegaptanib for neovascular age-related macular degeneration
Gragoudas, E. S., Adamis, A. P., Cunningham, E. T., Feinsod, M., & Guyer, D. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042760 · Cited by 2,337
RIG-I-mediated antiviral responses to single-stranded RNA bearing 5’-phosphates
Pichlmair, A., Schulz, O., Tan, C. P., Näslund, T. I., Liljeström, P., Weber, F., & Reis e Sousa, C. (2006) · Science · doi:10.1126/science.1132998 · Cited by 2,210
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
Soutschek, J., Akinc, A., Bramlage, B., Charisse, K., Constien, R., Donoghue, M., Elbashir, S., Geick, A., Hadwiger, P., Harborth, J., et al. (2004) · Nature · doi:10.1038/nature03121 · Cited by 2,183
Zamecnik, P. C., & Stephenson, M. L. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.1.280 · Cited by 1,792
MicroRNA-Directed Cleavage of HOXB8 mRNA
Yekta, S., Shih, I.-H., & Bartel, D. P. (2004) · Science · doi:10.1126/science.1097434 · Cited by 1,702
Specificity of microRNA target selection in translational repression
Doench, J. G., & Sharp, P. A. (2004) · Genes & Development · doi:10.1101/gad.1184404 · Cited by 1,636
LNA-mediated microRNA silencing in non-human primates
Elmén, J., Lindow, M., Schütz, S., Lawrence, M., Petri, A., Obad, S., Lindholm, M., Hedtjärn, M., Hansen, H. F., Berger, U., et al. (2008) · Nature · doi:10.1038/nature06783 · Cited by 1,589 · cited 1×
“) dosing of LNA-modifi ed oligonucleotides to African green monkeys (Elmen et al., 2008).”
Argonaute proteins: key players in RNA silencing
Hutvagner, G., & Simard, M. J. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2321 · Cited by 1,359
Regulation by let-7 and lin-4 miRNAs Results in Target mRNA Degradation
Bagga, S., Bracht, J., Hunter, S., Massirer, K., Holtz, J., Eachus, R., & Pasquinelli, A. E. (2005) · Cell · doi:10.1016/j.cell.2005.07.031 · Cited by 1,346
Doench, J. G., Petersen, C. P., & Sharp, P. A. (2003) · Genes & Development · doi:10.1101/gad.1064703 · Cited by 1,260
Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA
Judge, A. D., Sood, V., Shaw, J. R., Fang, D., McClintock, K., & MacLachlan, I. (2005) · Nature Biotechnology · doi:10.1038/nbt1081 · Cited by 1,250
Hornung, V., Guenthner-Biller, M., Bourquin, C., Ablasser, A., Schlee, M., Uematsu, S., Noronha, A., Manoharan, M., Akira, S., de Fougerolles, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1191 · Cited by 1,232
Interfering with disease: a progress report on siRNA-based therapeutics
de Fougerolles, A., Vornlocher, H.-P., Maraganore, J., & Lieberman, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2310 · Cited by 1,203
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs
Morrissey, D. V., Lockridge, J. A., Shaw, L., Blanchard, K., Jensen, K., Breen, W., Hartsough, K., Machemer, L., Radka, S., Jadhav, V., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1122 · Cited by 1,168
Illuminating the silence: understanding the structure and function of small RNAs
Rana, T. M. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2085 · Cited by 1,083
Strategies for silencing human disease using RNA interference
Kim, D. H., & Rossi, J. J. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2006 · Cited by 1,078
Unlocking the potential of the human genome with RNA interference
Hannon, G. J., & Rossi, J. J. (2004) · Nature · doi:10.1038/nature02870 · Cited by 1,064
Revealing the world of RNA interference
Mello, C. C., & Conte, D. (2004) · Nature · doi:10.1038/nature02872 · Cited by 997
Mechanisms and optimization of in vivo delivery of lipophilic siRNAs
Wolfrum, C., Shi, S., Jayaprakash, K. N., Jayaraman, M., Wang, G., Pandey, R. K., Rajeev, K. G., Nakayama, T., Charrise, K., Ndungo, E. M., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1339 · Cited by 974
Widespread siRNA “off-target” transcript silencing mediated by seed region sequence complementarity
Jackson, A. L., Burchard, J., Schelter, J., Chau, B. N., Cleary, M., Lim, L., & Linsley, P. S. (2006) · RNA · doi:10.1261/rna.25706 · Cited by 956
Sequence- and target-independent angiogenesis suppression by siRNA via TLR3
Kleinman, M. E., Yamada, K., Takeda, A., Chandrasekaran, V., Nozaki, M., Baffi, J. Z., Albuquerque, R. J. C., Yamasaki, S., Itaya, M., Pan, Y., et al. (2008) · Nature · doi:10.1038/nature06765 · Cited by 929
3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets
Birmingham, A., Anderson, E. M., Reynolds, A., Ilsley-Tyree, D., Leake, D., Fedorov, Y., Baskerville, S., Maksimova, E., Robinson, K., Karpilow, J., et al. (2006) · Nature Methods · doi:10.1038/nmeth854 · Cited by 920
Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide.
Stephenson, M. L., & Zamecnik, P. C. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.1.285 · Cited by 906
Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy
Kim, D.-H., Behlke, M. A., Rose, S. D., Chang, M.-S., Choi, S., & Rossi, J. J. (2005) · Nature Biotechnology · doi:10.1038/nbt1051 · Cited by 884
Self-citationsiRNA function in RNAi: A chemical modification analysis
CHIU, Y.-L., & RANA, T. M. (2003) · RNA · doi:10.1261/rna.5103703 · Cited by 860
Bartlett, D. W., Su, H., Hildebrandt, I. J., Weber, W. A., & Davis, M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707461104 · Cited by 803
Position-specific chemical modification of siRNAs reduces “off-target” transcript silencing
Jackson, A. L., Burchard, J., Leake, D., Reynolds, A., Schelter, J., Guo, J., Johnson, J. M., Lim, L., Karpilow, J., Nichols, K., et al. (2006) · RNA · doi:10.1261/rna.30706 · Cited by 789
Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA
Saito, T., Owen, D. M., Jiang, F., Marcotrigiano, J., & Gale, M. (2008) · Nature · doi:10.1038/nature07106 · Cited by 744
Progress towards in Vivo Use of siRNAs
Behlke, M. A. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.01.001 · Cited by 677
Self-citationFrank-Kamenetsky, M., Grefhorst, A., Anderson, N. N., Racie, T. S., Bramlage, B., Akinc, A., Butler, D., Charisse, K., Dorkin, R., Fan, Y., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805434105 · Cited by 642
Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells
Czauderna, F. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg393 · Cited by 623
Scacheri, P. C., Rozenblatt-Rosen, O., Caplen, N. J., Wolfsberg, T. G., Umayam, L., Lee, J. C., Hughes, C. M., Shanmugam, K. S., Bhattacharjee, A., Meyerson, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308698100 · Cited by 613
A conserved siRNA-degrading RNase negatively regulates RNA interference in C. elegans
Kennedy, S., Wang, D., & Ruvkun, G. (2004) · Nature · doi:10.1038/nature02302 · Cited by 592
In vivo activity of nuclease-resistant siRNAs
LAYZER, J. M., MCCAFFREY, A. P., TANNER, A. K., HUANG, Z., KAY, M. A., & SULLENGER, B. A. (2004) · RNA · doi:10.1261/rna.5239604 · Cited by 580
Design of Noninflammatory Synthetic siRNA Mediating Potent Gene Silencing in Vivo
Judge, A. D., Bola, G., Lee, A. C. H., & MacLachlan, I. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.11.002 · Cited by 571
Post-transcriptional gene silencing by siRNAs and miRNAs
Filipowicz, W., Jaskiewicz, L., Kolb, F. A., & Pillai, R. S. (2005) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2005.05.006 · Cited by 560
Locked nucleic acid (LNA) mediated improvements in siRNA stability and functionality
Elm n, J. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki193 · Cited by 559
Tolerance for mutations and chemical modifications in a siRNA
Amarzguioui, M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg147 · Cited by 534
RNA Interference in Mammalian Cells by Chemically-Modified RNA
Braasch, D. A., Jensen, S., Liu, Y., Kaur, K., Arar, K., White, M. A., & Corey, D. R. (2003) · Biochemistry · doi:10.1021/bi0343774 · Cited by 531
PERSENGIEV, S. P., ZHU, X., & GREEN, M. R. (2004) · RNA · doi:10.1261/rna5160904 · Cited by 530
Harborth, J., Elbashir, S. M., Vandenburgh, K., Manninga, H., Scaringe, S. A., Weber, K., & Tuschl, T. (2003) · Antisense and Nucleic Acid Drug Development · doi:10.1089/108729003321629638 · Cited by 474
Swayze, E. E., Siwkowski, A. M., Wancewicz, E. V., Migawa, M. T., Wyrzykiewicz, T. K., Hung, G., Monia, B. P., & Bennett, A. C. F. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl1071 · Cited by 469
Allerson, C. R., Sioufi, N., Jarres, R., Prakash, T. P., Naik, N., Berdeja, A., Wanders, L., Griffey, R. H., Swayze, E. E., & Bhat, B. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049167j · Cited by 448
Transcription and RNA interference in the formation of heterochromatin
Grewal, S. I. S., & Elgin, S. C. R. (2007) · Nature · doi:10.1038/nature05914 · Cited by 440
Levin, A. A. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00140-2 · Cited by 438
Small RNAs with Imperfect Match to Endogenous mRNA Repress Translation
Saxena, S., Jónsson, Z. O., & Dutta, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307089200 · Cited by 436
Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides
Juliano, R., Alam, M. R., Dixit, V., & Kang, H. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn342 · Cited by 429
Assembly and function of RNA silencing complexes
Sontheimer, E. J. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1568 · Cited by 423
Sioud, M. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.03.013 · Cited by 418
Progress in antisense technology
Crooke, S. T. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.55.091902.104408 · Cited by 417 · cited 1×
“A variety of chemically modifi ed antisense compounds have been successfully used for in vivo experimental biological studies and over a dozen candidate compounds are in various stages of clinical testing for use as therapeutic agents for a variety of disease indications (Crooke, 2004).”
Injected anti-sense RNAs specifically block messenger RNA translation in vivo.
Melton, D. A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.1.144 · Cited by 401
Innate immune responses to infection
Tosi, M. F. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.05.036 · Cited by 391
Interferon induction by siRNAs and ssRNAs synthesized by phage polymerase
Kim, D.-H., Longo, M., Han, Y., Lundberg, P., Cantin, E., & Rossi, J. J. (2004) · Nature Biotechnology · doi:10.1038/nbt940 · Cited by 382
Heidel, J. D., Yu, Z., Liu, J. Y.-C., Rele, S. M., Liang, Y., Zeidan, R. K., Kornbrust, D. J., & Davis, M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701458104 · Cited by 382
Marques, J. T., Devosse, T., Wang, D., Zamanian-Daryoush, M., Serbinowski, P., Hartmann, R., Fujita, T., Behlke, M. A., & Williams, B. R. (2006) · Nature Biotechnology · doi:10.1038/nbt1205 · Cited by 380
Self-citationA novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium
Santel, A., Aleku, M., Keil, O., Endruschat, J., Esche, V, Fisch, G., Dames, S., Löffler, K., Fechtner, M., Arnold, W., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302777 · Cited by 368
siRNA-mediated off-target gene silencing triggered by a 7 nt complementation
Lin, X. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki762 · Cited by 368
Activation of the mammalian immune system by siRNAs
Marques, J. T., & Williams, B. R. G. (2005) · Nature Biotechnology · doi:10.1038/nbt1161 · Cited by 358
Chemical modification of siRNAs to improve serum stability without loss of efficacy
Choung, S., Kim, Y. J., Kim, S., Park, H.-O., & Choi, Y.-C. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.049 · Cited by 348
Eguchi, A., Meade, B. R., Chang, Y.-C., Fredrickson, C. T., Willert, K., Puri, N., & Dowdy, S. F. (2009) · Nature Biotechnology · doi:10.1038/nbt.1541 · Cited by 340
Steroid and lipid conjugates of siRNAs to enhance cellular uptake and gene silencing in liver cells
Lorenz, C., Hadwiger, P., John, M., Vornlocher, H.-P., & Unverzagt, C. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.07.018 · Cited by 338
2′-O-methyl-modified RNAs Act as TLR7 Antagonists
Robbins, M., Judge, A., Liang, L., McClintock, K., Yaworski, E., & MacLachlan, I. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300240 · Cited by 336
Induction of the interferon response by siRNA is cell type– and duplex length–dependent
Reynolds, A., Anderson, E. M., Vermeulen, A., Fedorov, Y., Robinson, K., Leake, D., Karpilow, J., Marshall, W. S., & Khvorova, A. (2006) · RNA · doi:10.1261/rna.2340906 · Cited by 317
Efficient In Vivo Delivery of siRNA to the Liver by Conjugation of α-Tocopherol
Nishina, K., Unno, T., Uno, Y., Kubodera, T., Kanouchi, T., Mizusawa, H., & Yokota, T. (2008) · Molecular Therapy · doi:10.1038/mt.2008.14 · Cited by 312
Functional polarity is introduced by Dicer processing of short substrate RNAs
Rose, S. D. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki732 · Cited by 312
Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1
Shen, J., Samul, R., Silva, R. L., Akiyama, H., Liu, H., Saishin, Y., Hackett, S. F., Zinnen, S., Kossen, K., Fosnaugh, K., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302641 · Cited by 307
On the art of identifying effective and specific siRNAs
Pei, Y., & Tuschl, T. (2006) · Nature Methods · doi:10.1038/nmeth911 · Cited by 302
EDER, P. S., DeVINE, R. J., DAGLE, J. M., & WALDER, J. A. (1991) · Antisense Research and Development · doi:10.1089/ard.1991.1.141 · Cited by 293
Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication†
Morrissey, D. V., Blanchard, K., Shaw, L., Jensen, K., Lockridge, J. A., Dickinson, B., McSwiggen, J. A., Vargeese, C., Bowman, K., Shaffer, C. S., et al. (2005) · Hepatology · doi:10.1002/hep.20702 · Cited by 290
Cationic liposome-mediated delivery of siRNAs in adult mice
Sioud, M., & Sørensen, D. R. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.057 · Cited by 286
RNA interference using boranophosphate siRNAs: structure-activity relationships
Hall, A. H. S. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh936 · Cited by 285
Positional Effect of Chemical Modifications on Short Interference RNA Activity in Mammalian Cells
Prakash, T. P., Allerson, C. R., Dande, P., Vickers, T. A., Sioufi, N., Jarres, R., Baker, B. F., Swayze, E. E., Griffey, R. H., & Bhat, B. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050044o · Cited by 285
Designing siRNA That Distinguish between Genes That Differ by a Single Nucleotide
Schwarz, D. S., Ding, H., Kennington, L., Moore, J. T., Schelter, J., Burchard, J., Linsley, P. S., Aronin, N., Xu, Z., & Zamore, P. D. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020140 · Cited by 271
Grunweller, A. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg409 · Cited by 269
Du, Q. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki312 · Cited by 263
Minks, M. A., West, D. K., Benvin, S., & Baglioni, C. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86690-5 · Cited by 258
Biodistribution of phosphodiester and phosphorothioate siRNA
Braasch, D. A., Paroo, Z., Constantinescu, A., Ren, G., Öz, O. K., Mason, R. P., & Corey, D. R. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.12.074 · Cited by 251
DEVINCENZO, J., CEHELSKY, J., ALVAREZ, R., ELBASHIR, S., HARBORTH, J., TOUDJARSKA, I., NECHEV, L., MURUGAIAH, V, VLIET, A., & VAISHNAW, A. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2007.11.009 · Cited by 247
Toll-like receptors: a family of pattern-recognition receptors in mammals.
Armant, M. A., & Fenton, M. J. (2002) · Genome biology · doi:10.1186/gb-2002-3-8-reviews3011 · Cited by 246
Song, E., Lee, S.-K., Dykxhoorn, D. M., Novina, C., Zhang, D., Crawford, K., Cerny, J., Sharp, P. A., Lieberman, J., Manjunath, N., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.13.7174-7181.2003 · Cited by 230
Cationic lipids enhance siRNA-mediated interferon response in mice
Ma, Z., Li, J., He, F., Wilson, A., Pitt, B., & Li, S. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.041 · Cited by 225
siRNA and isRNA: two edges of one sword
Schlee, M., Hornung, V., & Hartmann, G. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.06.001 · Cited by 216
The human RNA kinase hClp1 is active on 3′ transfer RNA exons and short interfering RNAs
Weitzer, S., & Martinez, J. (2007) · Nature · doi:10.1038/nature05777 · Cited by 211
Sioud, M. (2006) · European Journal of Immunology · doi:10.1002/eji.200535708 · Cited by 201
Materializing the Potential of Small Interfering RNA via a Tumor-Targeting Nanodelivery System
Pirollo, K. F., Rait, A., Zhou, Q., Hwang, S. H., Dagata, J. A., Zon, G., Hogrefe, R. I., Palchik, G., & Chang, E. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4535 · Cited by 195
Improved silencing properties using small internally segmented interfering RNAs
Bramsen, J. B., Laursen, M. B., Damgaard, C. K., Lena, S. W., Ravindra Babu, B., Wengel, J., & Kjems, J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm548 · Cited by 192
Improvements in siRNA properties mediated by 2'-deoxy-2'-fluoro- -D-arabinonucleic acid (FANA)
Dowler, T. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl033 · Cited by 188
Manoharan, M. (2002) · Antisense and Nucleic Acid Drug Development · doi:10.1089/108729002760070849 · Cited by 185
Lack of interferon response in animals to naked siRNAs
Heidel, J. D., Hu, S., Liu, X. F., Triche, T. J., & Davis, M. E. (2004) · Nature Biotechnology · doi:10.1038/nbt1038 · Cited by 183
Santel, A., Aleku, M., Keil, O., Endruschat, J., Esche, V, Durieux, B., Löffler, K., Fechtner, M., Röhl, T., Fisch, G., et al. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302778 · Cited by 183
Evaluation of locked nucleic acid–modified small interfering RNA in vitro and in vivo
Mook, O. R., Baas, F., de Wissel, M. B., & Fluiter, K. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0195 · Cited by 182
Chen, P. Y., Weinmann, L., Gaidatzis, D., Pei, Y., Zavolan, M., Tuschl, T., & Meister, G. (2008) · RNA · doi:10.1261/rna.789808 · Cited by 176
Ui-Tei, K., Naito, Y., Zenno, S., Nishi, K., Yamato, K., Takahashi, F., Juni, A., & Saigo, K. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn042 · Cited by 176
Bartlett, D. W., & Davis, M. E. (2008) · Biotechnology and Bioengineering · doi:10.1002/bit.21668 · Cited by 164
Toxicology of antisense therapeutics
Jason, T. L. H., Koropatnick, J. D., & Berg, R. W. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.04.017 · Cited by 161
Heidel, J. D., Liu, J. Y.-C., Yen, Y., Zhou, B., Heale, B. S. E., Rossi, J. J., Bartlett, D. W., & Davis, M. E. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2218 · Cited by 160
TLR7 Is Involved in Sequence-Specific Sensing of Single-Stranded RNAs in Human Macrophages
Gantier, M. P., Tong, S., Behlke, M. A., Xu, D., Phipps, S., Foster, P. S., & Williams, B. R. G. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2117 · Cited by 159
Self-citationFluiter, K. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg185 · Cited by 158
Nallagatla, S. R., & Bevilacqua, P. C. (2008) · RNA · doi:10.1261/rna.1007408 · Cited by 156
Bartlett, D. W., & Davis, M. E. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.21285 · Cited by 153
Haupenthal, J., Baehr, C., Kiermayer, S., Zeuzem, S., & Piiper, A. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.11.015 · Cited by 151
Experimental validation of the importance of seed complement frequency to siRNA specificity
Anderson, E. M., Birmingham, A., Baskerville, S., Reynolds, A., Maksimova, E. M., Leake, D., Federov, Y., Karpilow, J. M., & Khvorova, A. (2008) · RNA · doi:10.1261/rna.704708 · Cited by 149
MALDI-TOF mass spectral analysis of siRNA degradation in serum confirms an RNAse A-like activity
Turner, J. J., Jones, S. W., Moschos, S. A., Lindsay, M. A., & Gait, M. J. (2006) · Molecular BioSystems · doi:10.1039/b611612d · Cited by 146
Kraynack, B. A., & Baker, B. F. (2005) · RNA · doi:10.1261/rna.2150806 · Cited by 144
Phosphorothioate Oligodeoxynucleotides: Antisense or Anti-Protein?
Krieg, A. Μ., & Stein, C. (1995) · Antisense Research and Development · doi:10.1089/ard.1995.5.241 · Cited by 127
Therapeutic siRNAs for dominant genetic skin disorders including pachyonychia congenita
Leachman, S. A., Hickerson, R. P., Hull, P. R., Smith, F. J. D., Milstone, L. M., Lane, E. B., Bale, S. J., Roop, D. R., McLean, W. H. I., & Kaspar, R. L. (2008) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2008.04.003 · Cited by 119
Mechanism of Action of CpG DNA
KRIEG, A. M., Hartmann, G., & Yi, A. (2000) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59672-8_1 · Cited by 116
Single-Nucleotide-Specific siRNA Targeting in a Dominant-Negative Skin Model
Hickerson, R. P., Smith, F. J. D., Reeves, R. E., Contag, C. H., Leake, D., Leachman, S. A., Milstone, L. M., McLean, W. H. I., & Kaspar, R. L. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701060 · Cited by 115
High potency silencing by single-stranded boranophosphate siRNA
Hall, A., Wan, J., Spesock, A., Sergueeva, Z. A., Shaw, B. R., & Alexander, K. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl339 · Cited by 114
Modifications in Small Interfering RNA That Separate Immunostimulation from RNA Interference
Eberle, F., Gießler, K., Deck, C., Heeg, K. M., Peter, M. E., Richert, C., & Dalpke, A. H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3229 · Cited by 113
Chemical Modification Patterns Compatible with High Potency Dicer-Substrate Small Interfering RNAs
Collingwood, M. A., Rose, S. D., Huang, L., Hillier, C., Amarzguioui, M., Wiiger, M. T., Soifer, H. S., Rossi, J. J., & Behlke, M. A. (2008) · Oligonucleotides · doi:10.1089/oli.2008.0123 · Cited by 112
Self-citationRobbins, M., Li, M., Leung, I., Li, H., Boyer, D. V., Song, Y., Behlke, M. A., & Rossi, J. J. (2006) · Nature Biotechnology · doi:10.1038/nbt1206 · Cited by 111
Self-citationLong‐lasting RNAi activity in mammalian neurons
Omi, K., Tokunaga, K., & Hohjoh, H. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00017-1 · Cited by 98
Short non-coding RNA biology and neurodegenerative disorders: novel disease targets and therapeutics
Weinberg, M. S., & Wood, M. J. A. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp070 · Cited by 84
Mechanisms and therapeutic applications of immune stimulatory CpG DNA
KRIEG, A. M. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00023-6 · Cited by 82
Yan, Z., Tiller, P. R., Chen, I., Beverly, M. B., & Hochman, J. H. (2008) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.3561 · Cited by 80
Analysis of siRNA specificity on targets with double-nucleotide mismatches
Dahlgren, C., Zhang, H., Du, Q., Grahn, M., Norstedt, G., Wahlestedt, C., & Liang, Z. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn190 · Cited by 71
Koldehoff, M., Steckel, N. K., Beelen, D. W., & Elmaagacli, A. H. (2007) · Clinical and Experimental Medicine · doi:10.1007/s10238-007-0125-z · Cited by 69
Grillone, L. R., & Lanz, R. (2001) · Drugs of today · doi:10.1358/dot.2001.37.4.620590 · Cited by 69
Whelan, J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03547-6 · Cited by 64
Wang, H., Ghosh, A., Baigude, H., Yang, C., Qiu, L., Xia, X., Zhou, H., Rana, T. M., & Xu, Z. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800834200 · Cited by 64
Peptide-oligonucleotide conjugates for the delivery of antisense and siRNA.
Juliano, R. L. (2005) · PubMed · Cited by 60
Central Delivery of Dicer-substrate siRNA: A Direct Application for Pain Research
Doré-Savard, L., Roussy, G., Dansereau, M., Collingwood, M. A., Lennox, K. A., Rose, S. D., Beaudet, N., Behlke, M. A., & Sarret, P. (2008) · Molecular Therapy · doi:10.1038/mt.2008.98 · Cited by 60
Self-citationShah, S., & Friedman, S. H. (2007) · Oligonucleotides · doi:10.1089/oli.2006.0067 · Cited by 59
Hogrefe, R. I., Lebedev, A. V., Zon, G., Pirollo, K. F., Rait, A. S., Zhou, Q., Yu, W., & Chang, E. H. (2006) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770600793885 · Cited by 56
Knockdown of TNFR1 by the sense strand of an ICAM-1 siRNA: dissection of an off-target effect
Clark, P. R., Pober, J. S., & Kluger, M. S. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm630 · Cited by 56
Haupenthal, J., Baehr, C., Zeuzem, S., & Piiper, A. (2007) · International Journal of Cancer · doi:10.1002/ijc.22665 · Cited by 52
Surface Calreticulin Mediates Muramyl Dipeptide-induced Apoptosis in RK13 Cells
Chen, D., Texada, D. E., Duggan, C., Liang, C., Reden, T. B., Kooragayala, L. M., & Langford, M. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413380200 · Cited by 51
Zamanian-Daryoush, M., Marques, J. T., Gantier, M. P., Behlke, M. A., John, M., Rayman, P. A., Finke, J. H., & Williams, B. R. G. (2008) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2007.0090 · Cited by 51
Self-citationDesign of active small interfering RNAs.
Peek, A. S., & Behlke, M. A. (2007) · PubMed · Cited by 51
Self-citationModified 27-nt dsRNAs with Dramatically Enhanced Stability in Serum and Long-Term RNAi Activity
Kubo, T., Zhelev, Z., Ohba, H., & Bakalova, R. (2007) · Oligonucleotides · doi:10.1089/oli.2007.0096 · Cited by 50
Viel, T., Boisgard, R., Kühnast, B., Jégo, B., Siquier-Pernet, K., Hinnen, F., Dollé, F., & Tavitian, B. (2008) · Oligonucleotides · doi:10.1089/oli.2008.0133 · Cited by 49
The effects of thiophosphate substitutions on native siRNA gene silencing
Li, Z.-Y., Mao, H., Kallick, D. A., & Gorenstein, D. G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.071 · Cited by 48
Richardson, F. C., Tennant, B. C., Meyer, D. J., Richardson, K. A., Mann, P. C., Mcginty, G. R., Wolf, J. L., Zack, P. M., & Bendele, R. A. (1999) · Toxicologic Pathology · doi:10.1177/019262339902700601 · Cited by 34
RNA Interference Tolerates 2′‐Fluoro Modifications at the Argonaute2 Cleavage Site
Muhonen, P., Tennilä, T., Azhayeva, E., Parthasarathy, R. N., Janckila, A. J., Väänänen, H. K., Azhayev, A. V., & Laitala‐Leinonen, T. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790073 · Cited by 32
Kubo, T., Zhelev, Z., Ohba, H., & Bakalova, R. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.10.116 · Cited by 31
Inhibition of SV40 gene expression by microinjected sma antisense RNA and DNA molecules
Graessmann, M., Michaels, G., Berg, B., & Graessmann, A. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.1.53 · Cited by 21
Oligoncleotide Analogues: An Overview
Matteucci, M. D. (2007) · Novartis Foundation symposium · doi:10.1002/9780470515396.ch2 · Cited by 14
Cited by
The current state and future directions of RNAi-based therapeutics
Setten, R. L., Rossi, J. J., & Han, S.-P. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0017-4 · Cited by 1,443
The evolution of commercial drug delivery technologies
Vargason, A. M., Anselmo, A. C., & Mitragotri, S. (2021) · Nature Biomedical Engineering · doi:10.1038/s41551-021-00698-w · Cited by 1,361
siRNA vs. shRNA: Similarities and differences
Rao, D. D., Vorhies, J. S., Senzer, N., & Nemunaitis, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.004 · Cited by 660
Advances in the delivery of RNA therapeutics: from concept to clinical reality
Kaczmarek, J. C., Kowalski, P. S., & Anderson, D. G. (2017) · Genome Medicine · doi:10.1186/s13073-017-0450-0 · Cited by 656
MicroRNA-Based Diagnosis and Therapy
Ho, P. T. B., Clark, I. M., & Le, L. T. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137167 · Cited by 630
Metadata
- Authors
- Behlke, M. A.
- Venue
- Oligonucleotides
- Publisher
- SAGE Publications
- Published
- 2008-12
- Volume
- 18
- Issue
- 4
- Pages
- 305-320
- ISSN
- 1545-4576 (ISSN-L)
- 1557-8526
- OpenAlex
- W2138733854
- Cited by
- 454
- References
- 153
- FWCI
- 14.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.